US Stock Crypto Market Starts Low but Soars, CRCL and FIGR Gain Over 8%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy FIGR?
Source: moomoo
US Stock Performance: US stock prices related to cryptocurrency opened lower but subsequently moved higher against the market trend.
Notable Increases: Several stocks saw significant increases, including Coinbase (2.38%), Circle (8.16%), and MicroStrategy (3.34%).
Additional Gains: Other stocks that rose include Gemini (1.58%), Bitmine (3.21%), and SharpLink Gaming (2.79%).
Further Increases: Stocks like Figure (8.03%), Kindly MD (2.33%), and Solana Co (2.14%) also experienced notable gains.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FIGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FIGR
Wall Street analysts forecast FIGR stock price to rise
7 Analyst Rating
6 Buy
1 Hold
0 Sell
Strong Buy
Current: 29.720
Low
50.00
Averages
54.67
High
62.00
Current: 29.720
Low
50.00
Averages
54.67
High
62.00
About FIGR
Figure Technology Solutions Inc., formerly FT Intermediate, Inc., is a blockchain-native capital marketplace that connects origination, funding, and secondary market activity. It operates and manages its business through FT Intermediate, Inc. (FTI) and Figure Markets Holdings, Inc. (Markets). The Company's proprietary technology enables next generation lending, trading and investing activities in areas, such as consumer credit and digital assets. Its application of the blockchain ledger allows it to serve its end-customers, improve speed and efficiency, and enhance standardization and liquidity. Its products include Figure HELOC, DSCR Loan, Cash-Out Refinance, Crypto-Backed Loan, Blog, Testimonials, and Repayment Assistance. It utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stablecoin deposits. Its Figure HELOCs offer investors a diversified and risk-adjusted return on the market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wall Street Rebounds at Midday, Driven by Strong Tech Stocks
- Market Rebound: Wall Street traded higher at midday on Monday, with the Nasdaq 100 gaining 0.3% to 25,025, indicating a recovery in investor sentiment as concerns over Middle East tensions eased.
- Tech Stocks Lead Gains: Palantir Technologies surged 6.5%, becoming the top performer in the S&P 500, suggesting a renewed confidence in tech stocks that could attract more investment into the sector.
- Energy Market Volatility: Oil prices rallied 5.1% to $70 per barrel, although they cooled after briefly hitting $75, with the energy sector rising 1.3% and Marathon Petroleum Corp. leading the group with a 4.5% gain.
- Rising Treasury Yields: The 10-year Treasury yield jumped 11 basis points to 4.07%, marking the largest one-day increase since April, reflecting heightened concerns about future economic prospects that may influence investor risk appetite.
See More
Astrana Health Reports Strong Quarterly Earnings, Shares Surge
- Earnings Beat: Astrana Health Inc. reported quarterly earnings of 54 cents per share, significantly surpassing the analyst consensus estimate of 11 cents, indicating a strong improvement in profitability and boosting market confidence in future growth.
- Sales Growth: The company achieved quarterly sales of $950.526 million, exceeding the analyst consensus estimate of $930.451 million, demonstrating robust demand for its products and competitive positioning, which may drive future investments and expansion.
- Stock Surge: Astrana Health's shares jumped 29.5% to $26.32 during Monday's session, reflecting a positive investor reaction to the strong earnings report, potentially attracting more institutional investors' interest.
- Market Context: While U.S. stocks were generally lower, with the Dow Jones index falling over 150 points, Astrana Health's strong performance highlights the resilience of individual stocks in uncertain market conditions, possibly providing new investment opportunities for investors.
See More
US Stock Crypto Market Starts Low but Soars, CRCL and FIGR Gain Over 8%
US Stock Performance: US stock prices related to cryptocurrency opened lower but subsequently moved higher against the market trend.
Notable Increases: Several stocks saw significant increases, including Coinbase (2.38%), Circle (8.16%), and MicroStrategy (3.34%).
Additional Gains: Other stocks that rose include Gemini (1.58%), Bitmine (3.21%), and SharpLink Gaming (2.79%).
Further Increases: Stocks like Figure (8.03%), Kindly MD (2.33%), and Solana Co (2.14%) also experienced notable gains.
See More
Figure Technology Solutions Misses Profit Expectations in Q4 2025
- Significant Revenue Growth: Figure Technology Solutions reported nearly $160 million in net revenue for Q4 2025, reflecting a robust 91% year-over-year increase, indicating strong market demand for its blockchain-driven mortgage and home equity loan services.
- Profitability Shortfall: Despite exceeding analyst expectations for revenue, with a consensus estimate of $158 million, the company's GAAP net income fell short at $15 million, or $0.06 per share, significantly below the anticipated $0.15 per share, leading to a sharp decline in investor confidence.
- Expansion of Loan Marketplace: The company's consumer loan marketplace volume surged to $2.7 billion, primarily driven by the adoption of the Figure Connect platform, which saw its volume skyrocket from $8 million to $1.5 billion year-over-year, demonstrating strong market acceptance of its innovative approach.
- Share Repurchase Program: Figure's board has authorized a stock repurchase program of up to $200 million, set to expire on February 27, 2027, signaling the company's confidence in its future growth prospects and commitment to enhancing shareholder value.
See More
Figure Technology's Q4 Earnings Miss Expectations
- Significant Revenue Growth: Figure Technology Solutions reported nearly $160 million in net revenue for Q4 2025, representing a substantial year-over-year increase of 91%, indicating strong market demand and business expansion potential in the fintech sector.
- Profitability Misses Expectations: Despite impressive revenue growth, the GAAP net income was only $15 million, translating to $0.06 per share, which fell short of analysts' expectations of $0.15 per share, leading to a decline in investor confidence.
- Robust Loan Marketplace Performance: The company's consumer loan marketplace saw transaction volume exceed $2.7 billion, primarily driven by the successful adoption of the Figure Connect platform, which surged from $8 million to $1.5 billion year-over-year, demonstrating market acceptance of its innovative model.
- Share Repurchase Program: The board of Figure Technology authorized a stock repurchase program of up to $200 million, aimed at enhancing shareholder value and stabilizing stock prices, set to expire on February 27, 2027, reflecting the company's confidence in future growth.
See More
Figure Technology Reports Mixed Q4 Results Amid Analyst Downgrades
- Earnings Highlights: Figure Technology reported Q4 earnings of 6 cents per share, missing the analyst estimate of 8 cents, yet quarterly sales reached $159.913 million, surpassing the $151.379 million forecast, indicating strong revenue performance.
- Significant Revenue Growth: The company saw a 91% year-over-year increase in net revenue, with adjusted net revenue hitting $158 million, up 106% from Q4 2024, showcasing substantial progress in its blockchain capital market operations.
- Strong Loan Market Performance: The Consumer Loan Marketplace volume reached $2.7 billion, a 131% increase year-over-year, with Figure Connect volume at $1.5 billion, up from $1.1 billion in Q3 2025, reflecting robust market demand.
- Analyst Rating Changes: Despite lowering price targets to $55, both Keefe, Bruyette & Woods and Needham maintained their Outperform and Buy ratings, respectively, indicating analysts' confidence in Figure's future growth potential.
See More
Wall Street Rebounds at Midday, Driven by Strong Tech Stocks
- Market Rebound: Wall Street traded higher at midday on Monday, with the Nasdaq 100 gaining 0.3% to 25,025, indicating a recovery in investor sentiment as concerns over Middle East tensions eased.
- Tech Stocks Lead Gains: Palantir Technologies surged 6.5%, becoming the top performer in the S&P 500, suggesting a renewed confidence in tech stocks that could attract more investment into the sector.
- Energy Market Volatility: Oil prices rallied 5.1% to $70 per barrel, although they cooled after briefly hitting $75, with the energy sector rising 1.3% and Marathon Petroleum Corp. leading the group with a 4.5% gain.
- Rising Treasury Yields: The 10-year Treasury yield jumped 11 basis points to 4.07%, marking the largest one-day increase since April, reflecting heightened concerns about future economic prospects that may influence investor risk appetite.
See More
Astrana Health Reports Strong Quarterly Earnings, Shares Surge
- Earnings Beat: Astrana Health Inc. reported quarterly earnings of 54 cents per share, significantly surpassing the analyst consensus estimate of 11 cents, indicating a strong improvement in profitability and boosting market confidence in future growth.
- Sales Growth: The company achieved quarterly sales of $950.526 million, exceeding the analyst consensus estimate of $930.451 million, demonstrating robust demand for its products and competitive positioning, which may drive future investments and expansion.
- Stock Surge: Astrana Health's shares jumped 29.5% to $26.32 during Monday's session, reflecting a positive investor reaction to the strong earnings report, potentially attracting more institutional investors' interest.
- Market Context: While U.S. stocks were generally lower, with the Dow Jones index falling over 150 points, Astrana Health's strong performance highlights the resilience of individual stocks in uncertain market conditions, possibly providing new investment opportunities for investors.
See More
US Stock Crypto Market Starts Low but Soars, CRCL and FIGR Gain Over 8%
US Stock Performance: US stock prices related to cryptocurrency opened lower but subsequently moved higher against the market trend.
Notable Increases: Several stocks saw significant increases, including Coinbase (2.38%), Circle (8.16%), and MicroStrategy (3.34%).
Additional Gains: Other stocks that rose include Gemini (1.58%), Bitmine (3.21%), and SharpLink Gaming (2.79%).
Further Increases: Stocks like Figure (8.03%), Kindly MD (2.33%), and Solana Co (2.14%) also experienced notable gains.
See More
Figure Technology Solutions Misses Profit Expectations in Q4 2025
- Significant Revenue Growth: Figure Technology Solutions reported nearly $160 million in net revenue for Q4 2025, reflecting a robust 91% year-over-year increase, indicating strong market demand for its blockchain-driven mortgage and home equity loan services.
- Profitability Shortfall: Despite exceeding analyst expectations for revenue, with a consensus estimate of $158 million, the company's GAAP net income fell short at $15 million, or $0.06 per share, significantly below the anticipated $0.15 per share, leading to a sharp decline in investor confidence.
- Expansion of Loan Marketplace: The company's consumer loan marketplace volume surged to $2.7 billion, primarily driven by the adoption of the Figure Connect platform, which saw its volume skyrocket from $8 million to $1.5 billion year-over-year, demonstrating strong market acceptance of its innovative approach.
- Share Repurchase Program: Figure's board has authorized a stock repurchase program of up to $200 million, set to expire on February 27, 2027, signaling the company's confidence in its future growth prospects and commitment to enhancing shareholder value.
See More
Figure Technology's Q4 Earnings Miss Expectations
- Significant Revenue Growth: Figure Technology Solutions reported nearly $160 million in net revenue for Q4 2025, representing a substantial year-over-year increase of 91%, indicating strong market demand and business expansion potential in the fintech sector.
- Profitability Misses Expectations: Despite impressive revenue growth, the GAAP net income was only $15 million, translating to $0.06 per share, which fell short of analysts' expectations of $0.15 per share, leading to a decline in investor confidence.
- Robust Loan Marketplace Performance: The company's consumer loan marketplace saw transaction volume exceed $2.7 billion, primarily driven by the successful adoption of the Figure Connect platform, which surged from $8 million to $1.5 billion year-over-year, demonstrating market acceptance of its innovative model.
- Share Repurchase Program: The board of Figure Technology authorized a stock repurchase program of up to $200 million, aimed at enhancing shareholder value and stabilizing stock prices, set to expire on February 27, 2027, reflecting the company's confidence in future growth.
See More
Figure Technology Reports Mixed Q4 Results Amid Analyst Downgrades
- Earnings Highlights: Figure Technology reported Q4 earnings of 6 cents per share, missing the analyst estimate of 8 cents, yet quarterly sales reached $159.913 million, surpassing the $151.379 million forecast, indicating strong revenue performance.
- Significant Revenue Growth: The company saw a 91% year-over-year increase in net revenue, with adjusted net revenue hitting $158 million, up 106% from Q4 2024, showcasing substantial progress in its blockchain capital market operations.
- Strong Loan Market Performance: The Consumer Loan Marketplace volume reached $2.7 billion, a 131% increase year-over-year, with Figure Connect volume at $1.5 billion, up from $1.1 billion in Q3 2025, reflecting robust market demand.
- Analyst Rating Changes: Despite lowering price targets to $55, both Keefe, Bruyette & Woods and Needham maintained their Outperform and Buy ratings, respectively, indicating analysts' confidence in Figure's future growth potential.
See More
